RA Capital Management, L.P. 13D and 13G filings for Aerovate Therapeutics, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2024-06-20 6:00 pm Purchase | 2024-06-17 | 13D | AEROVATE THERAPEUTICS INC AVTE | RA Capital Management, L.P. | 264,060 32.000% | 26,518 (+11.16%) | Filing |
| 2024-04-30 4:16 pm Purchase | 2024-04-26 | 13D | AEROVATE THERAPEUTICS INC AVTE | RA Capital Management, L.P. | 237,542 28.900% | 595 (+0.25%) | Filing |
| 2023-06-27 5:00 pm Purchase | 2023-06-26 | 13D | AEROVATE THERAPEUTICS INC AVTE | RA Capital Management, L.P. | 236,947 30.000% | 833 (+0.35%) | Filing |